|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-7-28
|
|
pubmed:abstractText |
Chemotherapy regimen containing anthracyclines has been used as the standard treatment for acute myeloid leukemia (AML). This study was to compare the efficacy and toxicity of the chemotherapy regimen containing perarubicin (THP) with that containing mitoxantrone (MIT) for young patients with newly diagnosed AML.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
619-25
|
|
pubmed:meshHeading |
pubmed-meshheading:19635200-Adolescent,
pubmed-meshheading:19635200-Adult,
pubmed-meshheading:19635200-Agranulocytosis,
pubmed-meshheading:19635200-Alopecia,
pubmed-meshheading:19635200-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19635200-Cytarabine,
pubmed-meshheading:19635200-Doxorubicin,
pubmed-meshheading:19635200-Female,
pubmed-meshheading:19635200-Humans,
pubmed-meshheading:19635200-Leukemia, Myeloid, Acute,
pubmed-meshheading:19635200-Male,
pubmed-meshheading:19635200-Middle Aged,
pubmed-meshheading:19635200-Mitoxantrone,
pubmed-meshheading:19635200-Nausea,
pubmed-meshheading:19635200-Recurrence,
pubmed-meshheading:19635200-Remission Induction,
pubmed-meshheading:19635200-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia.
|
|
pubmed:affiliation |
Department of Hematology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510080, P.R. China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
